Successful, we will reply to you quickly.OK
Please select the quantity.OK
Your message is being sent, please wait.Close
Send mail failed, please send again!Close
Products are for research use only. Not for human use. We do not sell to patients.
(BKM-120 hydrochloride; BKM120 hydrochloride; BKM 120 hydrochloride)
NVP-BKM120 Hydrochloride Chemical Structure
|Product name: NVP-BKM120 Hydrochloride|
|Cat. No.: HY-15180|
NVP-BKM120 Hcl(BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ.
IC50 value: 52 nM/166 nM/116 nM/262 nM(p110α/β/δ/γ) 
in vitro: BKM120 is not sensitive to Class III and Class IV PI3K's or PI4K. NVP-BKM120 shows great antiproliferation activity to PI3K deregulated cell lines including A2780, U87MG, MCF7 and DU145 with GI50 of 0.1-0.7 nM . BKM120 induces multiple myeloma cells (ARP1, ARK, MM.1S, MM1.R and U266) apoptosis, which results in increased G1-phase cells and decreased S-phase cells. BKM120 induced CD138+ primary MM cell apoptosis and has significant lower cytotoxicity toward CD138? stromal cells. BKM120 exposure could cause upregulation of BimS and downregulation of XIAP . BKM120 demonstrates antiproliferative activity in human gastric cancer cell lines by decreasing mTOR downstream signaling. BKM120 could increase either p-ERK or p-STAT3 in KRAS mutant gastric cancer cells. Combination with STAT3 blockade, BKM120 shows a synergism in cells harboring mutated KRAS by inducing apoptosis, but not in KRAS wild-type cells .
in vivo: BKM120 completely inhibits pAktser473 in A2780 xenograft tumors at doses of 30, 60, or 100 mg/kg, respectively. BKM120 also shows antitumor activity against U87MG glioma model at doses of 30 and 60 mg/kg . BKM120 treatment results in significantly reduced tumor volume and level of circulating human kappa chain at 5 μM/kg/day?1in ARP1 SCID mouse model, with prolonged survival .
|M.Wt||446.85||Storage||Please store the product under the recommended conditions in the Certificate of Analysis.|
|Solvent & Solubility||
10 mM in DMSO
|1 mg||5 mg||10 mg|
|1 mM||2.2379 mL||11.1894 mL||22.3789 mL|
|5 mM||0.4476 mL||2.2379 mL||4.4758 mL|
|10 mM||0.2238 mL||1.1189 mL||2.2379 mL|
|Product Name||Sponsor Only||Condition||Start Date||End Date||Phase||Last Change Date|
|NVP-BKM120 Hydrochloride||Novartis AG||Metastatic breast cancer||31-AUG-12||31-MAR-17||Phase 3||21-NOV-13|
|Novartis AG||Uterine cervix tumor||31-JAN-14||30-JUN-15||Phase 4||25-NOV-13|
|Novartis AG||Metastatic breast cancer||31-OCT-12||31-OCT-16||Phase 3||08-AUG-13|
|Washington University in St Louis||Breast tumor||31-JAN-14||31-JUL-15||Phase 2||17-OCT-13|
|Novartis AG||Breast tumor||30-NOV-13||31-MAY-16||Phase 2||12-SEP-13|
. Zheng Y, et al. Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone. J Mol Med (Berl), 2011 Dec 30.
3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3K(gamma) with IC50 of 25 (mu)M and 60 (mu)M.
A66 is a potent and specific p110(alpha) inhibitor with IC50 of 32 nM, >100 fold selectivity for p110(alpha) over other class-I PI3K isoforms.
Acalisib (GS-9820) is a potent and selective inhibitor of PI3K(delta) with IC50 value of 12.7 nM.
AMG319 is a potent and selective PI3K(delta) inhibitor with IC50 of 18 nM, also inhibits PI3K(gamma) with IC50 of 850 nM.
AS-252424 is a potent and selective inhibitor of PI3K(gamma) with IC50 of 33 nM; >10 fold selectivity for PI3K(gamma) versus PI3K(alpha).
AS-605240 is a potent and selective inhibitor of PI 3-kinase (gamma) (PI3K(gamma)) (IC50 = 8 nM). AS-605240 displays 30-fold selectivity over PI3K(delta) and PI3K(beta) and 7.5-fold selectivity over PI3K(alpha).
AZD6482 is a PI3K(beta) inhibitor with IC50 of 10 nM, 8-, 87- and 109-fold more selective to PI3K(beta) than PI3K(delta), PI3K(alpha) and PI3K(gamma).
AZD8835 is a potent and selective inhibitor of PI3K(delta) and PI3K(alpha)with IC50 of 5.7 nM and 6.2 nM, with selectivity against PI3K(beta) (IC50 431 nM) and PI3K(gamma) (IC50 90 nM).
AZD8186 is an isoform-specific small-molecule PI3K inhibitor, potently inhibits PI3K(beta) (IC50=4 nM) and PI3K(delta) (IC50=12 nM) with selectivity over PI3K(alpha) (IC50=35 nM) and PI3K(gamma) (IC50=675 nM).
BAY 80-6946(Copanlisib) is a potent and highly selective reversible PI3K inhibitor for PI3K(alpha)/(beta) with IC50 of 0.469 nM/3.72 nM.
Other Countries & RegionsSee Worldwide Distributors